BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108277
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108277
Table 1 General information and demographic characteristics of patients, n (%)
Items
Non-PNI group (n = 17)
PNI group (n = 65)
t
P value
Age (years), mean ± SD60.42 ± 4.3659.87 ± 3.250.4850.633
Gender (male/female)10 (58.82)/7(41.18)33 (50.77)/32 (49.23)0.1020.749
BMI (kg/cm2), mean ± SD25.64 ± 2.9824.85 ± 2.670.9870.334
Course of disease (months), mean ± SD5.46 ± 1.875.67 ± 2.010.4110.684
Smoking history (yes/no)7 (41.18)24 (36.92)0.0020.967
Drinking history (yes/no)8 (47.06)28 (43.08)0.0000.984
Family history of pancreatic cancer (yes/no)3 (17.65)14 (21.54)0.0000.987
Table 2 Comparison of clinical characteristics between the two groups of patients, n (%)
Clinical characteristics
Non-PNI group (n = 17)
PNI group (n = 65)
t
P value
Tumor location
Head7 (41.18)48 (73.85)-0.033
Body6 (35.29)10 (15.38)
Tail4 (23.53)7 (10.77)
Tumor size (cm), mean ± SD4.06 ± 0.895.37 ± 1.854.158< 0.001
CA19-9 Level, mean ± SD260.67 ± 48.92312.54 ± 57.623.745< 0.001
Overall survival (months), mean ± SD12.76 ± 3.219.85 ± 2.183.5310.002
Abdominal pain3 (17.65)32 (49.23)4.2790.039
Table 3 Comparison of pathological features between the two groups of patients, n (%)
Clinical characteristics
Non-PNI group (n = 17)
PNI group (n = 65)
t/χ2
P value
Pathological types-0.019
Ductal adenocarcinoma9 (52.94)42 (64.62)--
Mucinous adenocarcinoma5 (29.41)23 (35.38)
Adenosquamous carcinoma2 (11.76)0 (0.00)
Small cell carcinoma1 (5.88)0 (0.00)
Differentiation degree-< 0.001
Low2 (11.76)45 (69.23)--
Medium3 (17.65)14 (21.54)
High12 (70.59)6 (9.23)
Lymph node infiltration32.024< 0.001
Yes0 (0.00)51 (78.46)--
No17 (100.00)14 (21.54)
Table 4 Correlation analysis of the occurrence of neural infiltration in pancreatic cancer and clinical pathological features
Items
r
P value
Tumor location-0.2750.012
Tumor size (cm)0.3510.001
CA19-9 Level0.376< 0.001
Overall survival (months)-0.392< 0.001
Abdominal pain0.2590.019
Differentiation degree0.656< 0.001
Lymph node infiltration-0.2750.012